Development of an Orthogonal Protection Strategy for the Synthesis of Mycobacterial Arabinomannan Fragments

2015-11-20T00:00:00Z (GMT) by Kamar Sahloul Todd L. Lowary
<i>Mycobacterium tuberculosis</i>, the organism that causes tuberculosis (TB), has a carbohydrate-rich cell wall structure that possesses a number of immunogenic antigens. Circulating antibodies that recognize these glycans are present in patients infected by mycobacteria; detection of these antibodies could be the basis for new TB diagnostics. We describe here the synthesis of a panel of mycobacterial arabinomannan fragments for use in investigations directed at testing the feasibility of such a diagnostic method. In this study, we focused on structural motifs present in the core of the key immunogenic polysaccharide lipoarabinomannan (LAM). To access these compounds, we developed an efficient orthogonal protection strategy that allowed access to seven arabinomannan fragments of LAM (<b>1</b>–<b>7</b>). The targets included one tetrasaccharide, one pentasaccharide, three octasaccharides, and two nonasaccharides. Starting from a differentially protected trimannopyranoside derivative (<b>8</b> or <b>9</b>), the targets were obtained using an approach that involved selective removal of the protecting group present at the O-2 position of a single mannopyranoside residue, followed by glycosylation with a pentaarabinofuranose thioglycoside and/or a mannopyranose trichloroacetimidate.